Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD

被引:43
作者
Ulivelli, M
Rossi, S
Lombardi, C
Bartalini, S
Rocchi, R
Giannini, F
Passero, S
Battistini, N
Lugaresi, E
机构
[1] Univ Siena, UO Neurofisiopatol, Sez Neurol, Dipartimento Neurosci,Policlin Scotte, I-53100 Siena, Italy
[2] Univ Bologna, Ist Clin Neurol, Bologna, Italy
关键词
D O I
10.1212/WNL.58.3.462
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Both dopamine agonists and levodopa may induce episodes termed "sleep attacks" in patients with PD. These episodes are well details behaviorally, but little is known about their neurophysiologic characterization. The authors performed a 24-hour polysomnography (PSG) in a PD patient taking pergolide in combination with levodopa, in which four of these diurnal sleep episodes occurred. PSG findings were followed up after pergolide withdrawal. Sleep episodes shared with narcolepsy both behavioral and EEG findings. However, pergolide partly restored a more physiologic sleep architecture, which was disrupted during therapy with levodopa alone.
引用
收藏
页码:462 / 465
页数:4
相关论文
共 11 条
[1]   THE EFFECTS OF L-DOPA ON EXCESSIVE DAYTIME SLEEPINESS IN NARCOLEPSY [J].
BOIVIN, DB ;
MONTPLAISIR, J .
NEUROLOGY, 1991, 41 (08) :1267-1269
[2]   Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep (vol 10, pg 3111, 1999) [J].
Honda, K ;
Riehl, J ;
Mignot, E ;
Nishino, S .
NEUROREPORT, 1999, 10 (17) :3717-3724
[3]   Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease [J].
Karlsen, KH ;
Larsen, JP ;
Tandberg, E ;
Mæland, JG .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (04) :431-435
[4]   Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups [J].
Mignot, E ;
Lin, L ;
Rogers, W ;
Honda, Y ;
Qiu, XH ;
Lin, XY ;
Okun, M ;
Hohjoh, H ;
Miki, T ;
Hsu, SH ;
Leffell, MS ;
Grumet, FC ;
Fernandez-Vina, M ;
Honda, M ;
Risch, N .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :686-699
[5]  
Olanow CW, 2000, MOVEMENT DISORD, V15, P212, DOI 10.1002/1531-8257(200003)15:2<212::AID-MDS1002>3.0.CO
[6]  
2-6
[7]   Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors [J].
Perachon, S ;
Schwartz, JC ;
Sokoloff, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 366 (2-3) :293-300
[8]  
Rechtschaffen A., 1968, BRAIN INFORM SERVICE
[9]   Juvenile Parkinson's disease with REM sleep behavior disorder, sleepiness, and daytime REM onset [J].
Rye, DB ;
Johnston, LH ;
Watts, RL ;
Bliwise, DL .
NEUROLOGY, 1999, 53 (08) :1868-1870
[10]   Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings [J].
Tracik, F ;
Ebersbach, G .
MOVEMENT DISORDERS, 2001, 16 (03) :500-506